Biochemical individuality: The next generation

Regulatory Toxicology and Pharmacology

Volumn 24, Issue 1 II, 1996, Pages

  Calabrese, Edward J ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ANIMAL MODEL; BLADDER CANCER; CONFERENCE PAPER; DRUG SENSITIVITY; ENVIRONMENTAL IMPACT ASSESSMENT; GENETIC VARIABILITY; HEMOLYSIS; HEREDITY; HISTORY; HUMAN; LUNG CANCER; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL;

ANIMALS; CARCINOGENS, ENVIRONMENTAL; ENVIRONMENTAL ILLNESS; ENVIRONMENTAL POLLUTANTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METABOLISM, INBORN ERRORS; OCCUPATIONAL DISEASES; OCCUPATIONAL HEALTH; PHARMACOGENETICS;

ANIMALIA;

EID: 0029985039     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1996.0079     Document Type: Article

References (52)

1. Brewer, J. C. (1971). Annotations: Human ecology an expanding role for the human geneticist. Am. J. Hum. Gen. 23, 92-94.
2. Brieger, H. (1963). Genetic bases of susceptibility and resistance to toxic agents. J. Occup. Med. 5, 511-514.
3. Calabrese, E. J. (1979). An EPA-sponsored international conference on The Effects of Pollutants on Human High Risk Groups. Environ. Health Perspect. 29, 1-77.
4. Calabrese, E. J. (1983). Ecogenetics. John Wiley and Sons, New York.
5. Calabrese, E. J. (1984). Ecogenetics. John Wiley and Sons, Inc., New York.
6. Chakraborty, R., Schull, W. J., and Weiss, K. M. (1979). Heredity and risk of disease. In Conference on Evaluation of Environmental Biological Hazards and Competing Risk (Goerer, P., Ed.). Institute for Energy Analysis, Oak Ridge, TN.
7. Chakraborty, R., and Nei, M. (1976). Hidden genetic variability within electromorphs in finite populations. Genetics 84, 385-393.
8. Fuerst, P. A., Chakraborty, R., and Nei, M. (1977). Statistical studies on protein polymorphism in natural populations. I. Distribution of single locus heterozygosity. Genetics 86, 455-483.
9. Goble, F. C., and Konopka, E. A. (1973). Sex as a factor in infectious disease. Trans. N.Y. Acad. Sci. 35(2), 325-346.
10. Goldsmith, R. I., Rothhammer, F., and Schull, W. J. (1977). Heredity and mydriasis. Clin. Genet. 12, 129-133.
11. Haldane, J. B. S. (1938). Heredity and Politics, pp. 179-180. George Allen and Unwin Ltd., London.
12. Harris, H. (1975). The Principles of Human Biochemical Genetics. North Holland/Elsevier, New York.
13. Harris, H., and Whittaker, M. (1959). Differential response of human serum cholinesterase types to an inhibitor in potato. Nature 183, 1809.
14. Hayashi, S., Watanabe, J., and Kawajiri, K. (1992). Genetic susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione S-transferase genes. Jpn. J. Cancer Res. 83, 866-870.
15. Hughes, H. P., Biehl, J. P., Jones, A. P., and Schmidt, L. H. (1954). Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis. Ann. Rev. Tuberculosis 70, 166.
16. Jensen, W. N. (1962). Hereditary and chemically-induced anemia. Arch. Environ. Health 5, 212-216.
17. Johnson, J. D., Kretchmer, N., and Simoons, F. J. (1974). Lactose malabsorption: Its biology and history. Adv. Pediat. 21, 197-237.
18. Kalow, W. (1962). Pharmacogenetics: Heredity and the Response to Drugs. W. B. Saunders & Co., Philadelphia.
19. McKusick, V. A. (1970). Human genetics. Ann Rev. Genet. 4, 1.
20. Meier, H. (1963). Experimental Pharmacogenetics. Academic Press, New York.
21. Morse, H. C. Ill (Ed.) (1978). Origins of Inbred Mice. Academic Press, New York.
22. Motulsky, A. (1957). Drug reactions, enzymes, and biochemical genetics. JAMA 165, 835-837.
23. Motulsky, A. G. (1977). Ecogenetics: Genetic variation in susceptibility to environmental agents. In Human Genetics (Armandares, S., and Lisker, R., Eds.), pp. 375-385. Excerpta Medica, Amsterdam.
24. Mountain, J. T. (1963). Detecting hypersusceptibility to toxic substances. Arch. Environ. Health 6, 357.
25. Nakachi, K., Imai, K., Hayashi, S., and Kawajiri, K. (1993). Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 53, 2994-2999.
26. National Academy of Sciences (NAS) (1975). Special risk due to inborn error of metabolism. In Principles for Evaluating Chemicals in the Environment. National Academy of Sciences, Washington, DC.
27. Neel, J. V., Ferrell, R. E., and Conrad, R. A. (1976). The frequency of "rare" protein variants in Marshall Islanders and other Micronesians. Am. J. Hum. Genet. 28, 252-269.
28. Nei, M., and Roychoudhury, A. K. (1974). Genic variation within and between the three major races of man, Caucasoids, Negroids and Mongoloids. Am. J. Hum. Genet. 26, 421-443.
29. Ohta, T., Kimura, M. (1971). Functional organization of genetic material as a product of molecular evolution. Nature (Lond.) 233, 118-119.
30. Omenn, G. S., and Gelboin, H. V. (1984). Genetic Variability in Responses to Chemical Exposure. Cold Spring Harbor Laboratory, NY.
31. Pokrovsky, A. A. (1960). Action of alkaloids of sprouting potatoes on cholinesterase. Biokhimya 21, 705-709.
32. Price-Evans, D. A. (1963). Pharmacogenetics. Am. J. Med. 34, 639-662.
33. Propping, P. (1972). Comparison of point mutation rates in different species with human mutation rates. Humangenetik 16, 43-48.
34. Propping, P. (1978). Pharmacogenetics. Rev. Physiol. Biochem. Pharmacol. 83, 124-173.
35. Roche, L., Lejeune, E., Tolot, F., et al. (1960). Lead poisoning and thalassemia. Arch. Mal. Prof. Med. Trav. Secur. Soc. 21, 329.
36. Schull, W. J., Ferrell, R. E., and Rothhammer, F. (1978). Genes, enzymes and hypoxia. In Proc. Life Sciences, Ecological Genetics P. Brussard, ed., pp. 73-90. Springer-Verlag, New York.
37. Schull, W. J. (1979). Genetic structure of human populations. J. Env. Pathol. Toxicol. 2, 1305-1312.
38. Schuurs and Verheul. (1990). Effects of gender and sex steroids on the immune response. J. Steroid Biochem. 35(2), 157-172.
39. Stanberg, J. B., Wyngaarden, J. B., and Frederickson, D. S. (Eds.) (1960, 1972). The Metabolic Basis of Inherited Disease. McGraw Hill, New York.
40. Stokinger, H. E. (1962). New concepts and future trends in toxicology. Am. Ind. Hyg. Assoc. J. 23, 8.
41. Stokinger, H. E., and Mountain, J. T. (1963). Tests for hypersusceptibility to hemolytic chemicals. Arch. Environ. Health 6, 495-502.
42. Stokinger, H. E., Mountain, J. T., and Scheel, L. D. (1968). Pharmacogenetics in the detection of the hypersusceptible workers. Ann. NY Acad. Sci. 151, 968-976.
43. Strong, L. C. (1968). Biological Aspects of Cancer and Aging, p. 221. Pergamon Press, New York.
44. Szeinburg, A., Adams, A., Myeres, F., et al. (1959). A hematological survey of industrial workers with enzyme-deficient erythrocytes. Arch. Ind. Health 20, 510.
45. Tanis, R. J., Neel, J. V., Dovey, H., and Morrow, M. (1973). The genetic structure of a tribal population, the Yanomama Indians. IX. Gene frequencies for IB serum proteins and erythrocyte enzyme systems in the Yanomama and five neighboring tribes: Nine new variants. Am. J. Hum. Genet. 25, 665-676.
46. Viscount, C. (1917). Discussion on the origin, symptoms, pathology, treatment and prophylaxis of toxic jaundice observed in munitions workers. Proc. R. Soc. Med. 10, 6.
47. Vesell, E. S. (1973). Advances in pharmacogenetics. Prog. Med. Genet. 9, 291-367.
48. Vesell, E. S. (1987). Pharmacogenetic perspectives on susceptibility to toxic industrial chemicals. British J. Ind. Med. 44(8), 505-509.
49. Vineis, P., and Martone, T. (1995). Genetic-environmental interactions and low-level exposure to carcinogens. Epidemiology 6(4), 455-457.
50. Vogel, F. (1959). Modern problems of human genetics. Ergeb. Inn. Med. Kinderheilkd. 12, 52-125.
51. Yu, M. C., Skipper, P. L., Taghizadeh, K., Tannenbaum, S. R., Chan, K. K., Henderson, B. E., and Ross, R. K. (1994). Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black and Asian men in Los Angeles, California. J. Natl. Cancer Inst. 86, 712-716.
52. Zavon, M. R. (1962). Modern concepts of diagnosis and treatment in occupational medicine. Am. Ind. Hyg. Assoc. J. 23, 30.